ArriVent BioPharma (AVBP)
Develops licensed oncology assets led by firmonertinib and antibody-drug conjugates.
$30.32
After hours−0.03 (−0.10%)
At close$30.35(+2.05%)
Something off on this page? Send us feedback.
Next report
Nov 16, 26
estimated · in 55 days
EPS estimate
−$1.07
Revenue estimate
$800.0K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.60−$1.90−$0.90−$0.83−$0.78−$0.96−$1.05Pending
Estimate−$0.78−$0.66−$0.70−$0.78−$0.87−$0.88−$0.99−$1.07
Surprise+23.1%−187.9%−28.6%−6.4%+10.3%−9.1%−6.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate———————$800.0K
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.79 | — | — |
| Sep 2027 | −$0.92 | — | — |
| Jun 2027 | −$1.03 | — | — |
| Mar 2027 | −$1.00 | — | — |
| Dec 2026 | −$1.10 | — | — |
| Nov 2026 | −$1.07 | — | — |
| Aug 2026 | −$0.99 | −$1.05 | −6.3% |
| May 2026 | −$0.88 | −$0.96 | −9.1% |
| Mar 2026 | −$0.87 | −$0.78 | +10.3% |
| Nov 2025 | −$0.78 | −$0.83 | −6.4% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Sep 2023 | |||
| Aug 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.79 | — | — | $20.1M | — | — | — |
| Sep 2027 | −$0.92 | — | — | $10.6M | — | — | — |
| Jun 2027 | −$1.03 | — | — | $4.9M | — | — | — |
| Mar 2027 | −$1.00 | — | — | $4.9M | — | — | — |
| Dec 2026 | −$1.10 | — | — | $6.1M | — | — | — |
| Nov 16, 2026 | −$1.07 | — | — | $800.0K | — | — | — |
| Aug 12, 2026 | −$0.99 | −$1.05 | −6.3% | — | — | — | −4.6% |
| May 11, 2026 | −$0.88 | −$0.96 | −9.1% | — | — | — | −1.6% |
| Mar 5, 2026 | −$0.87 | −$0.78 | +10.3% | — | — | — | −4.9% |
| Nov 10, 2025 | −$0.78 | −$0.83 | −6.4% | — | — | — | +3.1% |
| Aug 11, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 3, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 8, 2024 | |||||||
| Mar 28, 2024 | |||||||
| Sep 30, 2023 | |||||||
| Aug 25, 2023 | |||||||
| Jun 30, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Dec 30, 2022 | |||||||
| Sep 29, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Mar 31, 2022 |